|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-12-3
|
|
pubmed:abstractText |
To investigate whether novel pharmacological preconditioning with diazoxide could protect the myocardial function and decrease myocardial injury in patients undergoing coronary artery bypass grafting (CABG).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1010-7940
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
967-73
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14643816-Aged,
pubmed-meshheading:14643816-Biological Markers,
pubmed-meshheading:14643816-Coronary Artery Bypass,
pubmed-meshheading:14643816-Creatine Kinase,
pubmed-meshheading:14643816-Creatine Kinase, MB Form,
pubmed-meshheading:14643816-Diazoxide,
pubmed-meshheading:14643816-Female,
pubmed-meshheading:14643816-Hemodynamics,
pubmed-meshheading:14643816-Humans,
pubmed-meshheading:14643816-Ischemic Preconditioning, Myocardial,
pubmed-meshheading:14643816-Isoenzymes,
pubmed-meshheading:14643816-Male,
pubmed-meshheading:14643816-Middle Aged,
pubmed-meshheading:14643816-Myocardial Stunning,
pubmed-meshheading:14643816-Postoperative Period,
pubmed-meshheading:14643816-Vasodilator Agents
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Novel pharmacological preconditioning with diazoxide attenuates myocardial stunning in coronary artery bypass grafting.
|
|
pubmed:affiliation |
Division of Cardiothoracic Surgery, Tampere University Hospital, Tampere, Finland.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
